Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center

被引:17
|
作者
Petrucca, A
Cipriani, P
Valenti, P
Santapaola, D
Cimmino, C
Scoarughi, GL
Santino, I
Stefani, S
Sessa, R
Nicoletti, M
机构
[1] Univ G DAnnunzio, Dipartimento Sci Biomed, I-66100 Chieti, Italy
[2] Azienda Osped St Andrea, Lab Microbiol Clin, I-00189 Rome, Italy
[3] Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, I-00185 Rome, Italy
[4] Univ Naples 2, Dipartimento Med Sperimentale, I-80135 Naples, Italy
[5] Dipartimento Biol Cellulare & Sviluppo, Sez Sci Microbiol, I-00185 Rome, Italy
[6] Univ Catania, Dipartimento Sci Microbiol & Ginecol, I-95124 Catania, Italy
关键词
B; cepacia; cystic fibrosis; genomovars; taxonomy;
D O I
10.1016/S0923-2508(03)00145-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacteria of the Burkholderia cepacia complex consist of a number of closely related genomic species (genomovars) potentially pathogenic for cystic fibrosis (CF) patients. collectively referred to as the B. cepacia complex. The genomovar status and epidemiological relatedness of B. cepacia complex strains recovered from CF patients, attending a CF Center at the University Hospital "Policlinico Umberto I" of Rome, were investigated using 16S rRNA PCR-RFLP, recA PCR-RFLP, genomovar-specific PCR, and RAPID. Forty-seven isolates identified as B. cepacia by commercial systems were repeatedly recovered from 19 CF patients. The taxonomy approach used in this study showed that 17 of the 19 patients were colonized by B. cepacia complex strains. Genomovar III (11 strains) was the most prevalent genomovar. Two strains of genomovar I. one B. stabilis (genomovar IV), one B. multivorans (genomovar II), and 4 strains of B. anthina (genomovar VIII) were also identified. This is the first report of multiple patient colonization by B. anthina in a CF center. The epidemiological and genetic relatedness as well as the presence of molecular markers associated with virulence and transmissibility of the B. cepacia complex strains were determined and probable patient-to-patient spread was observed. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:491 / 498
页数:8
相关论文
共 50 条
  • [41] Burkholderia cepacia complex infection in patients with cystic fibrosis
    Mahenthiralingam, E
    Baldwin, A
    Vandamme, P
    JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 51 (07) : 533 - 538
  • [42] Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients
    Coenye, T
    LiPuma, JJ
    Henry, D
    Hoste, B
    Vandemeulebroecke, K
    Gillis, M
    Speert, DP
    Vandamme, P
    INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2001, 51 : 271 - 279
  • [43] Exceptionally high representation of Burkholderia cepacia among B-cepacia complex isolates recovered from the major Portuguese cystic fibrosis center
    Cunha, Monica V.
    Pinto-de-Oliveira, Ana
    Meirinhos-Soares, Luis
    Salgado, Maria Jose
    Melo-Cristino, Jose
    Correia, Susana
    Barreto, Celeste
    Sa-Correia, Isabel
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (05) : 1628 - 1633
  • [44] Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa
    Hendry, J
    Butler, S
    Elborn, JS
    Govan, JRW
    Nelson, J
    Shale, DJ
    Webb, AK
    JOURNAL OF INFECTION, 2000, 40 (02) : 164 - 170
  • [45] The incidence of cepacia syndrome in CF patients colonised by ET12 Burkholderia cepacia
    Alapati, S
    Al-Aloul, M
    Miller, H
    Gavin, B
    Hart, CA
    Walshow, MJ
    Ledson, MJ
    THORAX, 2003, 58 : 66 - 66
  • [46] Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosis
    Moore, JE
    Xu, JR
    Millar, BC
    Crowe, M
    Elborn, JS
    JOURNAL OF MICROBIOLOGICAL METHODS, 2002, 49 (02) : 183 - 191
  • [47] In Vitro Activity of Doripenem against Burkholderia cepacia Complex Isolates from Non-Cystic Fibrosis Patients
    Singhal, Lipika
    Gautam, Vikas
    Kaur, Mandeep
    Ray, Pallab
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) : 1320 - 1321
  • [48] In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients
    Traczewski, MM
    Brown, SD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 819 - 821
  • [49] NONTUBERCULOUS MYCOBACTERIAL INFECTION IN CYSTIC FIBROSIS PATIENTS AT THE COLORADO CF CENTER
    Martiniano, S. L.
    Sontag, M. K.
    Nick, J. A.
    Sagel, S. D.
    PEDIATRIC PULMONOLOGY, 2011, : 304 - 304
  • [50] MOLECULAR CHARACTERIZATION OF MRSA IN CYSTIC FIBROSIS: TRANSMISSION WITHIN CF CENTRES?
    Gilpin, D.
    McGrath, S.
    McCaughan, J.
    Reid, A.
    Muhlebach, M. S.
    Hoffman, L. R.
    Burns, J. L.
    Jones, A. M.
    Elborn, S.
    Tunney, M.
    PEDIATRIC PULMONOLOGY, 2011, : 318 - 319